Moreover, the combination of both somatic and germline mosaicisms has been postulated to account also for another mechanism recently suggested in AxD, where the presence of a GFAP mutation only in a subset of cells in the parental generation could attenuate disease severity and delay the age of onset, thus leading to an apparent anticipation of symptoms in the offspring expressing the mutation ubiquitously. Here, GFAP is linked to Alexander disease.